Your browser doesn't support javascript.
loading
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase.
Murillo Perez, Carla F; Harms, Maren H; Lindor, Keith D; van Buuren, Henk R; Hirschfield, Gideon M; Corpechot, Christophe; van der Meer, Adriaan J; Feld, Jordan J; Gulamhusein, Aliya; Lammers, Willem J; Ponsioen, Cyriel Y; Carbone, Marco; Mason, Andrew L; Mayo, Marlyn J; Invernizzi, Pietro; Battezzati, Pier Maria; Floreani, Annarosa; Lleo, Ana; Nevens, Frederik; Kowdley, Kris V; Bruns, Tony; Dalekos, George N; Gatselis, Nikolaos K; Thorburn, Douglas; Trivedi, Palak J; Verhelst, Xavier; Parés, Albert; Janssen, Harry L A; Hansen, Bettina E.
Afiliação
  • Murillo Perez CF; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
  • Harms MH; Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Lindor KD; Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands.
  • van Buuren HR; College of Health Solutions, Arizona State University, Phoenix, Arizona.
  • Hirschfield GM; Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Corpechot C; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
  • van der Meer AJ; Centre de Re[Combining Acute Accent]fe[Combining Acute Accent]rence des Maladies Inflammatoires des VoiesBiliaires, Ho[Combining Circumflex Accent]pital Saint-Antoine, Paris, France.
  • Feld JJ; Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Gulamhusein A; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
  • Lammers WJ; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
  • Ponsioen CY; Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Carbone M; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, Netherlands.
  • Mason AL; Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
  • Mayo MJ; Divison of Gastroenterology and Hepatology, University of Alberta, Edmonton, Alberta, Canada.
  • Invernizzi P; Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas.
  • Battezzati PM; Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
  • Floreani A; Department of Health Sciences, Universita[Combining Grave Accent] degli Studi di Milano, Milan, Italy.
  • Lleo A; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Nevens F; Division of Internal Medicine and Hepatology, Humanitas Clinical Research Center IRCSS, Humanitas University, Rozzano (Milan), Italy.
  • Kowdley KV; Department of Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Bruns T; Liver Care Network, Swedish Medical Center, Seattle, Washington.
  • Dalekos GN; Department of Internal Medicine IV, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
  • Gatselis NK; Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Thorburn D; Department of Medicine and Research Laboratory of Internal Medicine, University of Thessaly, Larissa, Greece.
  • Trivedi PJ; Department of Medicine and Research Laboratory of Internal Medicine, University of Thessaly, Larissa, Greece.
  • Verhelst X; The Sheila Sherlock Liver Centre, The Royal Free Hospital, London, United Kingdom.
  • Parés A; National Institute for Health Research Birmingham Biomedical Research Centre and Centre for Liver Research, University of Birmingham, Birmingham, United Kingdom.
  • Janssen HLA; Department of Gastroenterology and Hepatology, Ghent University Hospital, Ghent, Belgium.
  • Hansen BE; Liver Unit, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain.
Am J Gastroenterol ; 115(7): 1066-1074, 2020 07.
Article em En | MEDLINE | ID: mdl-32618657
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ácido Ursodesoxicólico / Bilirrubina / Colagogos e Coleréticos / Colangite / Fosfatase Alcalina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Gastroenterol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ácido Ursodesoxicólico / Bilirrubina / Colagogos e Coleréticos / Colangite / Fosfatase Alcalina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Gastroenterol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá